Narcís Fernandez-Fuentes

19PUBLICATIONS
99CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursBiomolecular modelling and designMedical molecular engineering of nucleic acids and proteinsFormal methods for software
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (19)

|Aug 27, 2026
Tisa-cel and axi-cel CAR structure influences the development of resistance to CD19-CAR-T therapy.

|Jun 25, 2026
NG2-ITGA4 axis regulates Rho GTPases and leukemic aggressiveness in KMT2A-r B-ALL and is targetable with natalizumab.

|May 07, 2025
Computational Design and Evaluation of Peptides to Target SARS-CoV-2 Spike-ACE2 Interaction.

Saja Almabhouh, Erika Cecon, Florence Basubas

|Apr 04, 2025
LILRB1-directed CAR-T cells for the treatment of hematological malignancies.

Katsiaryna Marhelava, Klaudyna Fidyt, Monika Pepek

|Mar 16, 2025
A TIM-3-Fc decoy secreted by engineered T cells improves CD19 CAR T-cell therapy in B-cell acute lymphoblastic leukemia.

Aïda Falgàs, Rodrigo Lázaro-Gorines, Samanta Romina Zanetti

|Aug 02, 2024
NG2 is a target gene of MLL-AF4 and underlies glucocorticoid resistance in MLLr B-ALL by regulating NR3C1 expression.

Belén Lopez-Millan, Alba Rubio-Gayarre, Meritxell Vinyoles

Pageof 4

Frequent Collaborators

4 joint publications

Meritxell Vinyoles

4 joint publications

Baldo Oliva

4 joint publications

Mercedes Guerrero-Murillo

4 joint publications

Talía Velasco-Hernández